Skip to main content
OpenTrials

Clinical trial condition

Macular Edema

Explore clinical trials studying Macular Edema. Study availability and eligibility vary by location and protocol.

300 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Macular Edema trial results

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

NCT04635800

Conditions
Cardiovascular Diseases, Diabetic Macular Edema, Embolism and Thrombosis, +12 more
Locations
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Honolulu, Hawaii, United States
  • Novartis Investigative Site Hagerstown, Maryland, United States
  • Novartis Investigative Site Austin, Texas, United States
View Trial Details
Completed

NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)

NCT01331005

Conditions
Diabetic Macular Edema, Eye Diseases, Macular Degeneration, +3 more
Locations
  • Loma Linda University Health Care, Dept. of Ophthalmology Loma Linda, California, United States
  • Southern California Desert Retina Consultants, MC Palm Springs, California, United States
  • California Retina Consultants Santa Barbara, California, United States
  • Bay Area Retina Associates Walnut Creek, California, United States
View all 32 locations
View Trial Details
Completed

Cool vs Room-temperature Artificial Tears

NCT05832996

Conditions
CYSTOID MACULAR EDEMA, Central Retinal Vein Occlusion With Macular Edema, Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis), +16 more
Locations
  • University of Iowa Hospitals & Clinics - Department of Ophthalmology Iowa City, Iowa, United States
View Trial Details
Completed

To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular Edema

NCT04058067

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +10 more
Locations
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Shantou, Guangdong, China
  • Novartis Investigative Site Harbin, Heilongjiang, China
  • Novartis Investigative Site Wuhan, Hubei, China
View all 24 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion

NCT04740931

Conditions
Cardiovascular Diseases, Central Retinal Vein Occlusion, Embolism and Thrombosis, +10 more
Locations
  • Barnet Dulaney Perkins Eye Center Mesa, Arizona, United States
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • Retina Associates Southwest PC Tucson, Arizona, United States
  • Retinal Diagnostic Center Campbell, California, United States
View all 194 locations
View Trial Details

Related conditions